Save your place

Sign in to WhoBought

Please try again later.

Beam Therapeutics Inc. (BEAM) institutional ownership

Latest close $26.33 Jul 20, 2026
Market cap$2.1B 52-week range SectorHealthcare
Funds holding · Q1 2026
236
reported BEAM position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
136 buyers · 100 sellers

Beam Therapeutics Inc. (BEAM) price and institutional activity

Dates

Q1 2026

$0 bought by 136 investors
Adar1 Capital Management, LLCKynam Capital Management, LP +134 more
$0 sold by 100 investors
Woodline Partners LPMarshall Wace, LLP +98 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Beam Therapeutics Inc. (BEAM) institutional activity · 236

Investor Type Est. change Change Δ Own Date
Adar1 Capital Management, LLC · New
Change +1.4M Date Q1 2026
Adar1 Capital Management, LLC New· Q1 2026 +1.4M Q1 2026
Kynam Capital Management, LP · Added
Change +1.2M Date Q1 2026
Kynam Capital Management, LP Added· Q1 2026 +1.2M Q1 2026
Woodline Partners LP · Exited
Change −993K Δ Own −100.0% Date Q1 2026
Woodline Partners LP Exited· Q1 2026 −993K −100.0% Q1 2026
Deep Track Capital, LP · New
Change +821K Date Q1 2026
Deep Track Capital, LP New· Q1 2026 +821K Q1 2026
Marshall Wace, LLP · Reduced
Change −807K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −807K Q1 2026
Qube Research & Technologies Ltd · Added
Change +685K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +685K Q1 2026
Vanguard · Added
Change +593K Date Q1 2026
Vanguard Added· Q1 2026 +593K Q1 2026
Amova Asset Management Americas, Inc. · Reduced
Change −584K Date Q1 2026
Amova Asset Management Americas, Inc. Reduced· Q1 2026 −584K Q1 2026
Sumitomo Mitsui Trust Group, Inc. · Reduced
Change −584K Date Q1 2026
Sumitomo Mitsui Trust Group, Inc. Reduced· Q1 2026 −584K Q1 2026
FMR LLC · Added
Change +543K Δ Own +4.6% Date Q1 2026
FMR LLC Added· Q1 2026 +543K +4.6% Q1 2026
Contrarius Group Holdings Ltd · New
Change +533K Date Q1 2026
Contrarius Group Holdings Ltd New· Q1 2026 +533K Q1 2026
Two Sigma Advisers, LP · Exited
Change −528K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −528K −100.0% Q1 2026
Voloridge Investment Management, LLC · Exited
Change −492K Δ Own −100.0% Date Q1 2026
Voloridge Investment Management, LLC Exited· Q1 2026 −492K −100.0% Q1 2026
Goldman Sachs Group Inc · Added
Change +483K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +483K Q1 2026
State Street · Added
Change +471K Date Q1 2026
State Street Added· Q1 2026 +471K Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 236

Famous investor activity in Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Inc. (BEAM) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Simon Amy · Officer Sell −$13K
Price $34.73 Qty −373 Owned 102K ΔOwn −0.4% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Simon Amy Officer Sell $34.73 −373 −$13K 102K −0.4% Jun 30, 2026 Jul 2, 2026
Evans John M. · Director 2 operations −$858K
Price $34.26–$34.84 Qty −25K Owned 1.0M ΔOwn −2.3% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Evans John M. Director 2 operations $34.26–$34.84 −25K −$858K 1.0M −2.3% Jun 30, 2026 Jul 1, 2026
Evans John M. · Director 2 operations 0
Price $1.03 Owned 206K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Evans John M. Director 2 operations $1.03 0 206K Jun 30, 2026 Jul 1, 2026
Evans John M. · Director 2 operations −$887K
Price $35.13–$35.91 Qty −25K Owned 1.0M ΔOwn −2.3% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Evans John M. Director 2 operations $35.13–$35.91 −25K −$887K 1.0M −2.3% Jun 29, 2026 Jul 1, 2026
Evans John M. · Director 4 operations 0
Price $0.67–$1.03 Owned 231K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Evans John M. Director 4 operations $0.67–$1.03 0 231K Jun 29, 2026 Jul 1, 2026
FMR LLC · 10% Owner Sell −$8.9M
Price $35.26 Qty −251K Owned 855K ΔOwn −22.7% Trade date Jun 26, 2026 Filed date Jun 29, 2026
FMR LLC 10% Owner Sell $35.26 −251K −$8.9M 855K −22.7% Jun 26, 2026 Jun 29, 2026
FMR LLC · 10% Owner Sell −$1.2M
Price $35.12 Qty −33K Owned 1.1M ΔOwn −2.9% Trade date Jun 25, 2026 Filed date Jun 29, 2026
FMR LLC 10% Owner Sell $35.12 −33K −$1.2M 1.1M −2.9% Jun 25, 2026 Jun 29, 2026
Ciaramella Giuseppe · Officer 4 operations 0
Price $0.67–$1.03 Owned 57K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Ciaramella Giuseppe Officer 4 operations $0.67–$1.03 0 57K Jun 17, 2026 Jun 22, 2026
Shaw Christi · Director Grant (A) 20K
Owned 20K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Shaw Christi Director Grant (A) 20K 20K Jun 3, 2026 Jun 5, 2026
Walsh Kathleen E. · Director Grant (A) 20K
Owned 20K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Walsh Kathleen E. Director Grant (A) 20K 20K Jun 3, 2026 Jun 5, 2026
Maraganore John · Director Grant (A) 20K
Owned 20K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Maraganore John Director Grant (A) 20K 20K Jun 3, 2026 Jun 5, 2026
Fishman Mark · Director Grant (A) 20K
Owned 20K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Fishman Mark Director Grant (A) 20K 20K Jun 3, 2026 Jun 5, 2026
Guindo Chirfi · Director Grant (A) 20K
Owned 20K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Guindo Chirfi Director Grant (A) 20K 20K Jun 3, 2026 Jun 5, 2026
Cooper Graham K. · Director Grant (A) 20K
Owned 20K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Cooper Graham K. Director Grant (A) 20K 20K Jun 3, 2026 Jun 5, 2026
Evans John M. · Director Sell −$739K
Price $24.58 Qty −30K Owned 1.0M Trade date Apr 1, 2026 Filed date Apr 6, 2026
Evans John M. Director Sell $24.58 −30K −$739K 1.0M Apr 1, 2026 Apr 6, 2026
15 of 57
15 of 57 Sign in to continue to older insider transactions.

Beam Therapeutics Inc. (BEAM) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ark Investment Management LLC 9.4M
% of shares outstanding 11.5% Filing date Jan 29, 2024
Ark Investment Management LLC 9.4M 11.5% Jan 29, 2024
Blackrock, Inc. 7.7M
% of shares outstanding 9.4% Filing date Nov 8, 2024
Blackrock, Inc. 7.7M 9.4% Nov 8, 2024
Vanguard Group Inc 7.2M
% of shares outstanding 8.8% Filing date Feb 13, 2024
Vanguard Group Inc 7.2M 8.8% Feb 13, 2024
BlackRock Inc. 6.7M
% of shares outstanding 8.2% Filing date Jan 25, 2024
BlackRock Inc. 6.7M 8.2% Jan 25, 2024
FMR LLC 6.4M
% of shares outstanding 7.8% Filing date Nov 12, 2024
FMR LLC 6.4M 7.8% Nov 12, 2024
Arch Venture Fund Ix, L.P. 5.4M
% of shares outstanding 6.7% Filing date Feb 14, 2024
Arch Venture Fund Ix, L.P. 5.4M 6.7% Feb 14, 2024
Vanguard Capital Management LLC 5.1M
% of shares outstanding 5.0% Filing date Apr 29, 2026
Vanguard Capital Management LLC 5.1M 5.0% Apr 29, 2026
State Street Corp 3.9M
% of shares outstanding 4.8% Filing date Oct 17, 2024
State Street Corp 3.9M 4.8% Oct 17, 2024
8 of 10

Beam Therapeutics Inc. (BEAM) ownership FAQ

Who owns BEAM?

236 reporting institutions disclosed BEAM position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.